🐯虎嗅•Stalecollected in 22m
Impact of Medical Consortia on Drug Retail
💡Learn how centralized medical systems are reshaping the drug supply chain and where the next retail tech opportunities l
⚡ 30-Second TL;DR
What Changed
Medical consortia are consolidating procurement power, limiting prescription outflow from public hospitals.
Why It Matters
The retail pharmacy landscape is bifurcating into high-margin specialty stores and community-based health service hubs.
What To Do Next
If building health-tech solutions, focus on integrating with regional medical consortia's procurement APIs to bridge the gap between hospital and retail.
Who should care:Enterprise & Security Teams
Key Points
- •Medical consortia are consolidating procurement power, limiting prescription outflow from public hospitals.
- •Retail pharmacies must pivot to 'dual-channel' models to capture high-value specialty drug prescriptions.
- •The shift towards chronic disease management and high-cost innovative drugs creates a niche for specialized retail outlets.
- •Policy support for 'dual-channel' pharmacies remains a critical lifeline for the retail sector.
📰
Weekly AI Recap
Read this week's curated digest of top AI events →
👉Related Updates
AI-curated news aggregator. All content rights belong to original publishers.
Original source: 虎嗅 ↗